Shares of Reckitt Benckiser Group plc (LON:RKT – Get Free Report) have earned an average rating of “Moderate Buy” from the seven brokerages that are presently covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price target among brokerages that have covered the stock in the last year is GBX 6,242.86.
A number of research analysts have recently commented on the company. Citigroup lowered their target price on Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating for the company in a research note on Thursday, April 23rd. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a GBX 5,400 price objective on shares of Reckitt Benckiser Group in a research report on Thursday. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 5,900 target price on shares of Reckitt Benckiser Group in a research report on Wednesday, July 29th. Berenberg Bank lowered their price target on shares of Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating for the company in a research report on Friday, April 24th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and set a GBX 6,200 price objective on shares of Reckitt Benckiser Group in a research note on Wednesday, July 29th.
Check Out Our Latest Report on RKT
Insider Transactions at Reckitt Benckiser Group
Reckitt Benckiser Group Price Performance
Shares of Reckitt Benckiser Group stock opened at GBX 5,288 on Monday. The company has a quick ratio of 0.46, a current ratio of 0.59 and a debt-to-equity ratio of 179.24. Reckitt Benckiser Group has a 52 week low of GBX 3,866 and a 52 week high of GBX 6,522.92. The company has a market cap of £33.58 billion, a PE ratio of 10.87, a P/E/G ratio of 1.10 and a beta of 0.25. The business has a 50 day moving average of GBX 4,846.05 and a 200 day moving average of GBX 5,271.01.
Reckitt Benckiser Group (LON:RKT – Get Free Report) last posted its earnings results on Wednesday, July 29th. The company reported GBX 101.40 EPS for the quarter. Reckitt Benckiser Group had a net margin of 21.09% and a return on equity of 42.87%. As a group, equities research analysts forecast that Reckitt Benckiser Group will post 331.2110727 earnings per share for the current year.
Reckitt Benckiser Group Company Profile
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Featured Stories
- Five stocks we like better than Reckitt Benckiser Group
- 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
- AbbVie Quietly Solved Its Biggest Problem—Now What?
- Rio Tinto’s Results Make the Case for Looking Beyond Tech in the AI Trade
- Strategy’s Structural Strength: Hidden in a $8 Billion Illusion
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
